Arkema announced today that it has finalized the sale of Febex, a company specializing in phosphorus chemistry, to the Belgian Prayon group.

Febex is a global player in phosphorus products (high-purity phosphoric acid and sodium hypophosphite and derivatives), used mainly in the electronics and pharmaceutical industries.

Febex has sales of around 30 million euros in 2021, employs 59 people and operates 1 site in Switzerland.

'Arkema is thus pursuing the dynamic management of its portfolio of activities', says the company.

Copyright (c) 2023 CercleFinance.com. All rights reserved.